Please login to the form below

Not currently logged in
Email:
Password:

CEO pay

This page shows the latest CEO pay news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca chief on Brexit: “it’s going to be really painful”

AstraZeneca chief on Brexit: “it’s going to be really painful”

Soriot also claims to be lowest paid CEO in sector. AstraZeneca’s stockpiling of medicines ahead of Brexit is a temporary safeguard at best, and shortages could follow if no customs ... In a pair of articles in the Times and Sunday Times, AZ’s CEO

Latest news

  • Novartis lifts 2013 guidance on delay to Diovan generics Novartis lifts 2013 guidance on delay to Diovan generics

    Meanwhile, Novartis has revealed it will pay former CEO Daniel Vasella around $6m this year, assuming he takes up consultancy offers, which is a dramatic comedown from the original $72m 'golden ... The company will pay Vasella around $5.2m for services

  • Investor fury at Pfizer pay packages

    Investor fury at Pfizer pay packages. Shareholders protest at CEO's $83m pension during firm's annual meeting. ... At the meeting, Mead said McKinnell's pay had been reduced 22 per cent last year while Pfizer's share price fell 11 per cent.

  • Out in the open

    When the Trust finally received the HC report, CEO Rose Gibbs left immediately by mutual agreement. ... difficile. The media, local MPs and patients' relatives were therefore shocked to learn that the CEO had departed with a substantial pay off.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics